Home›Earnings›Results›Intuitive Surgical shares fall after Q2 revenue growth…

Intuitive Surgical shares fall after Q2 revenue growth but steady da Vinci guidance

Even with Q2 revenue up 19% to $2.89 billion and non-GAAP net income of $1.0 billion, investors focused on unchanged full-year guidance for da Vinci procedure growth.

Reported · Written up by our desk · Results

Intuitive Surgical posted a strong Q2 2026, with revenue rising 19% year over year to $2.89 billion and non-GAAP net income attributable to the company reaching $1.0 billion, or $2.80 per diluted share, up from $800 million, or $2.19 per diluted share, a year earlier, according to MarketBeat Ratings. The company also reported capital returns, repurchasing 0.9 million shares for $380 million during the quarter. It placed 468 da Vinci surgical systems versus 395 in the second quarter of 2025, including 246 da Vinci 5 systems compared with 180 a year earlier, and expanded its da Vinci installed base to 11,710 systems as of June 30, 2026, up 12% year over year. Despite those results, the stock fell about 10% in after-hours trading after the July 16 report. The main issue cited was that Intuitive Surgical did not raise its full-year guidance for da Vinci procedures, which was previously set at 13.5% to 15.5%, implying its slowest growth in several years.

off_topic_reason_extra_unused_field_is_ignored_by_system

More like this

Sources